Switching to lumateperone improves weight gain, schizophrenia symptoms

Intra-Cellular Therapies recently announced data that indicated improvements in weight gain and cardiometabolic, endocrine and schizophrenia outcomes after switching from standard antipsychotic care to lumateperone with no dose titration in individuals with schizophrenia



When this will be out …!!!

Can anyone work out exactly how much weight that is in lbs. .01 doesn’t sound like much.

It doesn’t say how many lbs were lost. Only that weight loss was statistically significant.

1 Like

May be out in 1-2 years If everything goes ok is my guess.

1 Like